We could confirm that the activator members of E2F family, namely E2F1 and E2F2, showed also an up-regulation in tumor samples compared to normal samples (Fig. S1B), confirmed by the previously described overexpression of E2F3a in this NMIBC dataset4. The gene discussed is E2F2; the disease is neoplasm.